DEC 18, 2019 11:24 AM PST

A tool that simplifies the hunt for cancer drugs

WRITTEN BY: Nouran Amin

Cells have long been the internal hubs for proteins that hold a wide variety of unique functions. Disorders on how a cell synthesizes a protein can affect a lot of our physiology and predispose to a multitude of symptoms leading to a diseases such as cancer. In fact, many drugs are developed to target a protein responsible for a particular disorder.

Learn more about protein synthesis:

Scientists curious about which drugs affect what kinds of proteins may now have a tool that can determine exactly that. Specifically, scientists at Karolinska Institutet have now utilized these methods to generate a tool that can produce reliable and precise results. They developed the tool through testing lung and breast cancer and intestinal tumor cells with 56 different kinds of drugs. For each drug compound, they first determined the dose that kills half of the cells after 48 hours (LC50) and then used that dose on all other drugs.

The tool is referred to as the ‘ProTargetMiner’.

Findings of the study were published in Nature Communications and describes that when half of the cells die, each proteome (a structure in the cell in which proteins are present) will show which and what proteins were targeted by an added drug. Results of experiments are made available through an online database and researchers are hopeful to expand their database through continues studies.

"We find that the cells are killed in different ways by different drugs," says Roman Zubarev, professor of medical proteomics at Karolinska Institutet. "Not so long ago we used to think that cells could only die in three ways -- necrosis, apoptosis or autophagy -- but now we've observed at least thirteen different ways in which cells can die. This method can help to speed up certain parts of the process of new drug development or improve our understanding of existing drugs."

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 14, 2020
Drug Discovery & Development
JAN 14, 2020
Can Silica Treat Obesity and Diabetes?
Silica particles, specifically ‘mesoporous silica particles (MSPs)’ are engineered molecular traps that may provide a breakthrough treatment op...
JAN 20, 2020
Cell & Molecular Biology
JAN 20, 2020
Using Modified Red Blood Cells As a Drug Delivery System
For a drug to be effective, it has to get to the right place to exert its impact....
FEB 25, 2020
Drug Discovery & Development
FEB 25, 2020
China Approves Trials for Favipiravir to Treat Coronavirus
As of February 25th 2020, there have been 80, 354 reported cases of COVID-19 (Wuhan coronavirus), including 2,707 deaths and 27,898 recoveries. Currently w...
MAR 05, 2020
Drug Discovery & Development
MAR 05, 2020
Molecule Found in Oranges Could Treat Obesity
Scientists at Western University isolated a molecule from oranges and sweet tangerines called ‘nobiletin’. Through the studies on mice the mole...
MAR 23, 2020
Drug Discovery & Development
MAR 23, 2020
Is Fast-Tracking Vaccines for Coronavirus Really Such a Good Idea?
Donald Trump has called on researchers to “slash red tape like nobody has even done it before” to accelerate the development of vaccines for th...
MAR 29, 2020
Neuroscience
MAR 29, 2020
Anti-Inflammatory May Prevent Memory Loss from Alzheimer's
Around 5.5 million people in the US suffer from Alzheimer’s Disease. Now, research has found that reducing the body’s inflammatory response may...
Loading Comments...